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coagulation cascades. Interaction of a serpin with its target proteinase induces a large conformational change,
resulting in insertion of its reactive center loop (RCL) into the main body of the protein as a new strand
within beta-sheet A. Intermolecular insertion of the RCL of one serpin molecule into the beta-sheet A of
another leads to polymerization, a widespread phenomenon associated with a general class of diseases known
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modulation of alpha(1)-antitrypsin (alpha(1)-AT) polymerization and depolymerization, and employ a
statistical computationally-assisted design strategy (SCADS) to identify new tetrapeptides that modulate
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SUMMARY
Members of the serine proteinase inhibitor (serpin) family play important roles in the inflammatory
and coagulation cascades. Interaction of a serpin with its target proteinase induces a large
conformational change, resulting in insertion of its reactive center loop (RCL) into the main body of
the protein as a new strand within β-sheet A. Intermolecular insertion of the RCL of one serpin
molecule into the β-sheet A of another leads to polymerization, a widespread phenomenon associated
with a general class of diseases known as serpinopathies. Small peptides are known to modulate the
polymerization process by binding within β-sheet A. Here we use fluorescence correlation
spectroscopy (FCS) to probe the mechanism of peptide modulation of α1-antitrypsin (α1-AT)
polymerization and depolymerization, and employ a statistical computationally-assisted design
strategy (SCADS) to identify new tetrapeptides that modulate polymerization. Our results
demonstrate that peptide-induced depolymerization takes place via a heterogeneous, multi-step
process which begins with internal fragmentation of the polymer chain. One of the designed
tetrapeptides is the most potent antitrypsin depolymerizer yet found.
Keywords
serpin polymerization; α1-antitrypsin; computer design; fluorescence correlation spectroscopy
(FCS); serpin depolymerization
INTRODUCTION
Serine proteinase inhibitors (serpins) are a superfamily of proteins that control a wide variety
of biological events, such as inflammation, coagulation and fibrinolysis.1-4 Serpin structure
is characterized by the presence of a central β-sheet A (the largest of the three β-sheets) flanked
by two shorter β-sheets B and C, and a mobile, inhibitory 14-residue reactive center loop (RCL)
(see Figure 1).5-8 The RCL directly interacts with the protease and can either remain fully
exposed or upon proteolysis become partially or fully inserted into the five stranded β-sheet
A.8-13 More specifically, binding of a serpin to its target proteinase not only results in the
cleavage of the RCL but also initiates a significant conformational change that ultimately
results in residues P1 – P14 of the cleaved RCL incorporating into β-sheet A as β-strand s4A.
5,7,8,14 This process is commonly referred to as the S (stressed) to R (relaxed) transition during
which the protease is translocated ∼70 Å from the proximal to the distal end of the serpin
molecule. In addition, some serpins undergo spontaneous intramolecular insertion of the intact
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RCL into the A β-sheet, leading to formation of a latent form that has a more stable fold than
the active form.12-15
While an exposed RCL is necessary for serpin function, its proclivity to undergo β-sheet
insertion makes serpin molecules vulnerable to polymerization. In the latter process, the RCL
of one molecule inserts into the β-sheet of another, forming loop-sheet linkages16-21 that
appear on electron micrographs as flexible beads-on-a-string.7,19 (See Figure 1.) Polymer
formation sequesters a serpin in an inactive form and is associated with diseases such as
thrombosis, angiodema and dementia.19 α1-Antitrypsin (α1-AT) protects the lung tissues
against the proteolytic action of the enzyme neutrophil elastase and its deficiency is the most
extensively studied of the serpin related diseases, referred to collectively as ‘serpinopathies’.
19 While over 70 naturally occurring α1-AT variants have been identified and characterized,
the S (Glu264→Val) and Z (Glu342→Lys) variants are the most clinically relevant and arise as
a result of point mutations in the α1-AT gene.19 These mutations lead to formation of α1-AT
polymers under physiological conditions that are retained in the endoplasmic reticulum of the
liver, predisposing the homozygote to juvenile hepatitis, cirrhosis and hepatocellular
carcinoma.22-26
Ensemble measurements of fluorescence and CD changes, coupled with PAGE analysis, have
led to formulation of a two-step mechanism of α1-AT polymerization in which a relatively fast
intramolecular conformational change within momomeric α1-AT is followed by a
polymerization step involving intermolecular loop-sheet insertion.27-29 In addition, the
overall rate of polymerization has been shown to vary with concentration, temperature and pH.
28,30,31 More recently, using single-molecule fluorescence correlation spectroscopy (FCS)
we have shown that α1-AT polymerization is a heterogeneous process that proceeds via a
nucleation and growth model, whereby longer polymers form via the condensation of two
shorter polymers, and in which the nature of the “nucleus” is a variable dependent on
experimental conditions.31 Despite this variability in the self-association process, α1-AT
polymers show a clear preference for species having 8 to 16 monomer units, consistent with
the results of electron microscopic analysis.7
Peptides corresponding to sequences within residues P14-P1 of the RCL have been shown to
anneal to the β-sheet A of a native serpin by a mechanism analogous to the loop-sheet insertion,
thereby preventing further polymerization5,31-34. Recently, Zhou et al. have identified small
peptides unrelated to the serpin RCL sequence that not only block the polymerization of α1-
AT and antithrombin, but also depolymerize antithrombin polymers.35 Although this study
did not provide a detailed description of the mechanism of the depolymerization process, it did
include structural information showing that one such peptide, WMDF, occupies the P7-P4
vacancy in s4A site of antithrombin such that the P6 and P4 sidechains (M and F) are bound in
well-defined hydrophobic pockets.35 Depolymerization results with other tetrapeptides
reinforces the notion that effective disassembly of serpin polymers depends on binding
hydrophobic residues into these pockets.
In this paper we use the results of Zhou et al. as a starting point both to probe the mechanism
of small peptide-induced serpin depolymerization and to systematically design and identify
short peptide sequences (tetrapeptides) that are effective in breaking up serpin polymers.
Peptides likely to bind in the middle strand of the A β-sheet have been designed based on a
statistical, computationally-assisted design strategy (SCADS).35-38 SCADS considers the
protein structure atomistically using a molecular force field and has been applied successfully
to suggest solutions to several recent protein design problems.38-44
Depolymerization of a linear polymer can proceed either via sequential deletion of monomer
units from the ends of the polymers or via fragmentation into shorter polymeric strands due to
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cleavage between protein monomers within the polymer interior (see Figure 2). We distinguish
between these possibilities by using fluorescence correlation spectroscopy (FCS) that measures
the temporal intensity fluctuations caused by the diffusion of single fluorescent molecules into
and out of a detection volume.45-57 Such measurements allow the monitoring of the length
distribution of species formed during polymerization and depolymerization, according to their
respective diffusion times. Our results show that depolymerization proceeds via a
heterogeneous, multi-step process which begins with internal fragmentation of the polymer
chain, although later in the process both sequential deletion and fragmentation become
important.
RESULTS
FCS measurement
As described previously,30 the autocorrelation function, G(τ), obtained in a FCS experiment
provides information about the residence time of a fluorescent molecule in the laser excitation
volume element.49 For a given confocal microscopy setup, the residence time, τD, provides a
direct measure of the molecule's diffusion constant and hydrodynamic radius (see Materials
and Methods). Therefore, FCS is capable of measuring the size of a particle or molecular
species diffusing through the confocal volume and can be used to examine the size distribution
of the polymeric species at a specific reaction time during serpin polymerization or
depolymerization. In addition, from the amplitude of the autocorrelation function at zero lag
time (τ= 0), i.e., G(0), one can also confirm the number of molecules within the volume element,
and thus the sample concentration.45-49 Because G(0) varies inversely with the number of
molecules in the confocal volume, it increases during serpin polymerization, as shorter
precursors are converted into longer polymers, and decreases during serpin depolymerization
as longer polymers dissociate into shorter oligomers (see Figure 3).
WMDF inhibition of α1-AT polymerization
Earlier30 we showed that, at least up to 55 °C, raising the temperature increases both the rate
of formation and the average length of α1-AT polymers. The results presented in Figure 4 show
that the added WMDF inhibits α1-AT polymerization at 39 °C, but does not block the formation
of α1-AT polymers at 52 °C. Furthermore, preincubation of α1-AT with WMDF for 24 hours
at 39 °C followed by increase of sample temperature to 52 °C led to the formation of longer
polymeric species (data not shown). As WMDF inhibition of polymerization presumably
involves competition for a common binding site in α1-AT, these results thus suggest that the
polymeric forms of α1-AT are more stable than the WMDF-α1-AT complex at 52 °C. A similar
finding has also been reported by Parfrey et al. for a hexapeptide-Z-AT complex,58 and is
further supported by similar results with one of the designed peptides, VIKF (data not shown),
as referred to below. Consequently, depolymerization studies with WMDF and other peptides
were carried out at 39 °C.
WMDF induction of the depolymerization of α1-AT polymers
As shown in Figure 3, autocorrelation traces taken at different times of incubation of α1-AT
polymers with WMDF clearly indicate a time-dependent depolymerization process,
characterized by decreases in both G(0) and τD. While either parameter is a reliable monitor
of the polymerization/depolymerization process,30 below we will use only τD to characterize
the size of the intermediate polymeric α1-AT species formed during the course of
depolymerization.
A more detailed view of the depolymerization process induced by WMDF was obtained by
determining the distributions of different diffusing species over a 24 day incubation period (see
Figure 5). The distribution is initially dominated by the presence of species with τD values in
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the range of 27 – 35 ms (Day 1), corresponding to polymers consisting of 13 – 18 α1-AT
monomer units.30 The initial distribution of the diffusion times is little changed during the
first few days of the depolymerization reaction, corresponding to a lag phase. With increasing
incubation time, especially from the 7th day onwards, faster diffusing species (e.g., τD = 12 -
15 ms) appear, consistent with depolymerization. From this point, the shift in the center of the
distribution to smaller τD values becomes more apparent, concomitant with the disappearance
of species with longer diffusion times. Depolymerization is nearly complete by the 24th day,
with a τD distribution similar to that obtained on a freshly prepared monomeric α1-AT sample,
which contains small amounts of dimer and trimer.30
SCADS Design
We have used SCADS to design additional peptides that could not only block α1-AT self-
assembly but also potentially reverse α1-AT polymerization efficiently. This method yields the
site-specific probabilities of the amino acids at variable positions in a particular structure (or
structural template) and its details have been described elsewhere.36-38 In the current study,
the x-ray crystal structure of the antithrombin-WMDF complex (pdb code: 1JVQ)35 was used
as the structural template to re-design tetrapeptide sequences that are effective in blocking
α1-AT polymerization. For these sequence calculations, the coordinates of the peptide
backbone atoms were constrained to those of the WMDF peptide. Only four sites are allowed
to mutate, those residing on the peptide (P7-P4). All the other residues, including those of
antithrombin, were fixed in their wild type conformations as presented in the protein databank
structure 1JVQ.35 Because the peptide is buried within the antithrombin structure, no effective
solvation energies were used in the calculations.37 The wild type peptide WMDF has only one
charged residue. Hence, it is of interest to relocate the position of the ionizable group to each
of the four positions. The sequences were thus constrained to have one charged residue and
three hydrophobic residues, resulting in four computationally identified blocking peptides,
each having an ionizable amino acid (K, R, E, D) at one of the four sites. Two rounds of
calculations were performed. In the first round, all 20 amino acids were allowed at all four
positions (position P7-P4), and all four sites were varied simultaneously. This first round of
calculation identified those sites having a strong preference for an ionizable amino acid (R, K,
D or E). In the second round, each of the four sites was targeted for an ionizable amino acid.
For a given targeted position of a charged amino acid: if the first round calculation indicated
that R, K, D, or E was most probable at the targeted position, the identity was fixed to this most
probable amino acid and the remaining sites were varied; otherwise, only charged amino acids
(R, K, D and E) were allowed. In each case, at the remaining three positions, only hydrophobic
amino acids were permitted (A, V, I, L, W, F, M and G). After this second round of calculation,
the identities of all sites were determined as the most probable amino acids at each site. These
calculations yielded four sequences, with ionizable amino acids at sites P7 through P4,
respectively: DIIF, VEIF, VIKF, and VIID. Note the dissimilarity between these peptides and
WMDF; even the designed peptide with an ionizable group targeted at the P5 position (D in
WMDF) has an amino acid (K) of opposite charge.
Depolymerization of α1-AT polymers by designed peptides
Only two of the four SCADS-designed peptides, VIKF and VEIF, were sufficiently soluble in
aqueous buffer to be useful in studies of α1-AT depolymerization. The depolymerization
process induced by VIKF (see Figure 6) gave results similar to those obtained with WMDF,
but proceeded with an overall rate that was noticeably faster (compare, for example, the
distributions obtained after 7th day of incubation in Figures 5 and 6). Depolymerization was
confirmed at the ensemble level by nondenaturing PAGE analysis (Figure 7). Such analysis
shows a dominant monomer band for unheated TMR-labeled α1-AT, and confirms the shift to
highly aggregated forms on prolonged heating at 45 °C, a large fraction of which are unable
to enter into the gel. Incubation of the aggregated protein for 21 days in the presence of VIKF
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at 39 °C results in conversion to monomers, which is even more complete than what is seen
for the unheated sample.
The overall average diffusion times as a function of the incubation period are compared in
Figure 8 for VIKF, VEIF, WMDF, and FLKK. The latter served as a negative control since it
was selected on the basis of its inconsistency with the computationally determined site-specific
probabilities. These results, showing VIKF and VEIF to effectively induce depolymerization
whereas FLKK does not, indicate that SCADS provides a promising approach to the design of
small peptides capable of inducing depolymerization. Reducing peptide concentration from
200 μM to 25 μM led to much slower rates of depolymerization (data not shown).
Depolymerization induced by WMDF, VIKF, and VEIF proceeds via what appears to be a
four-phase process. An initial lag phase of 5 – 7 days over which τD maintains an average value
of 26 – 28 ms is followed by a decrease over several days to reach an apparent plateau
characterized by an average τD value of 15 – 18 ms. The duration of this plateau phase, which
is clearly visible in the case of VEIF but also discernible with WMDF and VIKF, is variable
(2 – 7 days), and is followed by another decrease toward a final value of ∼2 ms.
DISCUSSION
Serpin polymerization resulting from aberrant β-sheet aggregation leads to a variety of
diseases.1,2,13,19,22,23 Several studies have focused on identifying peptides that may
prevent5,31-33, or even reverse35 this process. While these studies have shown promising
results, the methods used are nevertheless empirical, qualitative and not structure-based. A
more rational design approach that leverages the structural information available for serpins
and serpin-peptide complexes should facilitate the discovery of sequences having potential
therapeutic applications. Using FCS, we investigated the size distribution of polymeric species
during α1-AT depolymerization in the presence of WMDF and several designed peptides. Not
only do the results verify the effectiveness of the computationally designed sequences, but they
also provide new insights into the understanding of the mechanism of serpin depolymerization,
a process about which little had been known heretofore.
Mechanism of depolymerization
The results presented above permit some initial conclusions and speculations regarding the
mechanism of peptide-induced depolymerization of α1-AT polymers. Inspection of Figures 5
and 6 shows that formation of species with τD values ≤ 6 ms (monomers to trimers) only takes
place during the third and fourth phases of depolymerization (see Figure 8), so that the decrease
in τD values during the second phase must arise exclusively via internal fragmentation of the
polymer chains. This is essentially the reverse of our previous observation that, during α1-AT
polymerization, the final, condensation of shorter oligomers.30 Consequently, the second
phase of depolymerization can be viewed as the reversal of the final phase of the polymerization
process, with the first phase (or lag period) plausibly attributed to peptide binding and
conformational changes accompanying such binding.
While WMDF and VEIF display very similar first and second phases of depolymerization, the
third phase is markedly longer for VEIF. A possible interpretation of this difference is that
transition to the 4th phase may require peptide interaction with a binding site that is distinct
from the one involved in phases 1 and 2. The time-dependent distributions shown in Figures
5 and 6 should allow formulation of a quantitative model for the depolymerization process,
and efforts in this direction are underway.
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Insights from the designed sequences
The designed peptides can be used to explore the allowed amino acids at each position of the
tetrapeptide. As suggested in a previous study,35 the P4 and P6 positions prefer less polar
amino acids, since these residues may insert into hydrophobic pockets in the region where they
bind to the protein (see Figure 9). This might be the reason why VEIF has the least efficiency
among the three peptides shown in Figure 8. Glutamic acid being a negatively charged residue
at the P6 position may give rise to unfavorable desolvation upon its entry into a hydrophobic
pocket, hence leading to lower affinity and consequently a delay in breaking up of α1-AT
polymers. The increased efficiency of VIKF over WMDF may result from the facts that
isoleucine (I) is more hydrophobic and less flexible than methionine (M), while valine (V) is
both hydrophobic and sterically less demanding than tryptophan (W), thereby leading to better
packing/binding of VIKF inside the cavity of α1-AT. The inability of FLKK to act as a blocking
agent towards α1-AT polymerization highlights the intrinsic importance of having a
hydrophobic residue at the P4 position for achieving a high binding affinity. This is consistent
with the observation that peptides efficient in blocking and depolymerizing all have a
phenylalanine (F) at the P4 position.35
Furthermore, while the current design sequences were generated based on the crystal structure
of the antithrombin-WMDF complex,35 they nevertheless prove to be effective even for
disassembling α1-AT polymers. This is consistent with the similarity of the antithrombin and
antitrypsin structures in the vicinity of the peptide binding site. Therefore, this study
demonstrates the applicability of the SCADS method towards the design of peptide sequences
for serpin depolymerization. When combined with more accurate structural templates that
closer represent the target protein, α1-AT rather than antithrombin, the method may lead to the
design of peptides with more efficient depolymerization properties. In addition, the method
presented here can be extended to rationally design therapies involving both peptide and non-
peptide mimetics that can be used to treat antitrypsin deficiencies. For example, it could be
used to design peptides that primarily target the clinically relevant Z-form of antitrypsin rather
than the normal (M) form.58
CONCLUSION
In summary, we have used fluorescence correlation spectroscopy, a technique with single
molecule sensitivity, to gain insights into the understanding of the serpin depolymerization
mechanism by small peptides. The results show that depolymerization is indeed very
heterogeneous in its evolution as observed from the multitude of species present.
Depolymerization appears to proceed via a combination of internal fragmentation of polymers
and sequential deletion of monomeric units (especially at the later stage of depolymerization).
The SCADS method provides a systematic approach towards the rational design of short
peptides that would not only block but also break-up preformed α1-AT polymers. One of the
designed sequences shows improvement in the kinetic efficiency of serpin depolymerization
compared to WMDF, indicating that such computer aided design approach is promising for
future studies related to therapies relevant to serpinopathies.
MATERIALS AND METHODS
SCADS Design
In order to make a judicious choice for the selection of peptides that can efficiently block and
reverse α1-AT polymerization, we have used the computation assisted design strategy
SCADS50,51 as described below.
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Structure template—The WMDF-bound antithrombin structure (1JVQ)35 was used as the
structural template to design peptide(s) to block α1-AT polymerization. The new peptide was
designed as a tetrapeptide, located at P7-P4 position. For these sequence calculations, the
coordinates of the backbone atoms were constrained to those of the WMDF peptide.
Sequence design—SCADS (statistical, computationally-assisted design strategy) is used
for identifying amino acid probabilities from a given backbone structure. The method takes as
input (a) a target structure, (b) the energy functions that quantify sequence-structure
compatibility, and (c) a set of energetic or other constraints on the sequences. In the
calculations, a backbone dependent rotamer library59 was used, with 81 rotamers for each
amino acid residue in the calculations. For calculating the side chain - backbone and side chain
- side chain interaction energies, the AMBER potential60 with a modified hydrogen bonding
term61 was used to quantify van der Waals, electrostatic, and hydrogen bonding energies. All
such energies were measured with respect to a “reference energy” that depends upon amino
acid identity and crudely approximates intramolecular energetic interactions in the
unstructured and unbound state.38 The output is the site-specific probabilities of the rotamers
of each amino acid, which yield the site-specific amino acid probabilities that guide the
sequence selection. In this method, the conformational energy has a conjugate inverse
temperature Tc; as reported previously the probabilities used for design purposes here were
determined at Tc = 0.5 mol/kcal.37
Materials
Expression and Purification of the C232S/S359C α1-Antitrypsin Variant—The
protocols used to prepare the α1-antitrypsin variant used in the current study have been
described in detail previously.30
Preparation of P1'-TMR-Labeled α1-Antitrypsin—C232S/S359C-α1-antitrypsin was
reacted with excess tetramethylrhodamine (TMR) dye and excess of buffer C (tris-(2-
carboxyethyl)phosphine hydrochloride (Molecular Probes) in 5 mL of 50 mM Tris/50 mM
KCL buffer, pH 8.3). The reaction was allowed to proceed overnight in dark at 4 °C and was
quenched by excess β-mercaptoethanol. Excess dye was removed following the protocol
reported earlier.30 The extent of labeling of AT at the P1' position was determined using the
TMR extinction coefficient of 52000 M−1cm−1 at its isosbestic point and was found to be 1.04
TMR/protein. Protein concentration was determined by the bicinchoninic acid (BCA, Pierce,
Rockford, IL) assay.
Peptide Synthesis—The peptides (WMDF, VIKF, VEIF, DIIF, VIID and FLKK) used in
the current study were synthesized by standard solid phase Fmoc based peptide synthesis
protocols on an automated peptide synthesizer (Protein Technologies Inc.). The peptides were
then cleaved from the resin and subsequently purified by reverse phase HPLC. Each of the
purified peptides had the appropriate mass as determined by electrospray mass ionization
spectrometry.
Depolymerizing Experiments by PAGE Analysis
TMR-labeled α1-AT (7.0 μM) in 50 mM Tris/50 mM KCL buffer (pH 8.3) was initially
incubated at 45 °C for 24 hours to ensure complete polymerization. It was then mixed with
200-fold molar excess peptide (VIKF) and aliquots were removed at various time points, and
brought to room temperature by dilution with 5 volumes of the same buffer. Samples were
analyzed by non-denaturing polyacrylamide gradient gels (4-15%, BioRad, Hercules, CA) as
previously described30. Protein was visualized by silver staining. Densiometric analysis was
performed using NIH Image software, version 1.61.
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Blocking and Depolymerizing Experiments by FCS
For the blocking experiments, two protein samples, one containing 7 μM TMR-labeled α1-AT
and another containing 7 μM of TMR-labeled α1-AT plus 1.4 mM WMDF (the concentration
of WMDF was determined by tryptophan absorbance at 280 nm using ε280 = 5600
M−1cm−1), were incubated at either 39 or 52 °C. At predetermined time intervals aliquots were
removed and quickly diluted with buffer solution (Tris/KCl, pH = 8.3) at room temperature
(23 °C) to give a final concentration of 1 nM in α1-AT. This procedure halts further
polymerization or depolymerization.30 Diluted samples were used immediately for FCS
measurements. The total observation time for each FCS measurement is 100 seconds with an
integration time of 100 μs for each point. Typically at least 30 to 35 such measurements were
taken (for data presented in Figure 4) for each diluted sample. A similar protocol was followed
for the depolymerization experiments, in which 7 μM TMR-labeled α1-AT was first incubated
at 45 °C for about 36 hours to ensure the formation of significant amount of α1-AT polymers.
30 In the following step, the temperature was decreased to 39 °C and the tetrapeptide of interest
was added in 200-fold molar excess from stock solutions made up in 50 mM Tris buffer (pH
8.3). Concentrations of VIKF, VEIF and FLKK were determined by phenylalanine absorbance,
using ε257 = 197 M−1cm−1. Aliquots were removed each day and quickly diluted with buffer
solution at room temperature to give a final α1-AT concentration of 1 nM. At least 50
independent FCS traces (Figures 5 and 6) were collected for each diluted sample.
FCS Measurements
FCS is based on the measurement of temporal intensity fluctuations caused by one or several
fluorescent molecules diffusing in and out of a well-defined excitation volume element,
45-57 and the characteristic autocorrelation function G(τ) can be obtained by correlating photon
bursts according to the following equation:
(1)
where δF(t) = F(t)− < F(t) > is the fluorescence intensity fluctuation at time t. The temporal
decay of G(τ) contains information about the characteristic timescales of the dynamic processes
causing the fluorescence fluctuations, such as diffusion, binding reactions, triplet state blinking,
and conformational changes, among others.47,48,55
The confocal fluorescence microscope used is similar to those described in other studies.55
Briefly, the excitation source (∼270 μW) at 514.5 nm was derived from the laser lines of an
Ar+ laser (Spectra-Physics, Mt. View, CA), which was brought to a focus in the sample solution
by a microscope objective (Nikon 100X, NA 1.3, oil-immersion). The emission was collected
by the same objective and was separated from the excitation by a dichroic mirror. The confocal
volume was defined by a 50 μm pinhole. A single interference filter was used to allow only
the fluorescence to pass through and reach the detector. Photon counting in real time was done
by an avalanche photodiode detector (SPCM-AQR-16, Perkin-Elmer, Vaudreuil, Canada) and
a data acquisition card (PCI-6602, National Instruments, Austin, TX). A computer program
written in LABVIEW (National Instruments, Austin, TX) was used to control the data
collection as well as the subsequent autocorrelation analysis. Prior to every experiment, the
confocal microscope system was calibrated by FCS measurements of the characteristic
diffusion time of R6G (Molecular Probes).
For a prolate ellipsoidal Gaussian observation volume the autocorrelation function G(τ) arising
from diffusion can be described by the following equation:55
(2)
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where n represents the number of fluorescent species in solution, τ is the lag time, τiD is the
characteristic diffusion time of species i during which it resides in the observation volume, ω
signifies the axial (z0) to lateral (r0) dimension ratio of the volume element, N denotes the mean
number of fluorescent molecules in the time limit τ → 0, i.e., G(τ→ 0) = 1/N, and fi signifies
the fraction of species i in the solution. For a specific confocal microscopic setup, the diffusion
time (τD) is related to the diffusion constant (D) through the following equation:
(3)
where r0 = 0.3 μm for our setup. For a spherical diffusing species, the hydrodynamic radius
(Rh) is related to the diffusion constant via the following Stokes-Einstein relationship:49
(4)
where kB is the Boltzmann constant, T is the absolute temperature, and η is the viscosity of the
solvent.
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Figure 1.
Structure of α1-antitrypsin (M) with the β-sheet A in green and the mobile RCL in red. Polymer
formation results from Z-mutation (Glu342→Lys, as indicated by arrow) or aberrant opening
of shutter domain to form an unstable intermediate, M*. The β-sheet accepts a loop from
another molecule to form a dimer D that finally extends to polymers P. Each α1-AT molecule
in the polymer is shown in a different color (Reproduced with permission from: D.A. Lomas,
D. Belorgey, M. Mallya, E. Miranda, K.J. Kinghorn, L.K. Sharp, R.L. Phillips, R. Page, A.S.
Robertson and D.C. Crowther, 2005, Biochemical Society Transactions, 33, 321-330. © the
Biochemical Society).
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Figure 2.
A schematic representation of the two possible modes of serpin depolymerization. The
sequential deletion mode only involves cleavage of monomeric units from the end of a serpin
polymer, whereas the fragmentation mode is characterized by breaking up a longer polymer
into two shorter pieces.
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Figure 3.
Representative FCS traces corresponding to different reaction times of the depolymerization
of α1-AT by WMDF obtained at 39 °C: (a) Day 1, (b) Day 14, and (c) Day 24. These data were
modeled by Eq. (2) with two components. The fast component has a diffusion time of ∼200
μs and was attributed to residual amount of free dye molecules present in the sample, whereas
the slow component was assigned to TMR-labeled α1-AT species (monomer/oligomer/
polymer) diffusing in and out of the confocal volume. The corresponding diffusion times of
the slow component are: (a) τD = 30 ms, (b) τD = 10 ms, and (c) τD = 2.5 ms. The concomitant
decrease in both values of τD and G(0) as a function of reaction time indicates depolymerization.
Error in the reported diffusion times is estimated to be ∼±15%.
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Figure 4.
Distribution of diffusion times of α1-AT samples with and without the blocking peptide
(WMDF). The incubation temperature was 39 °C for panels A-D and 52 °C for panels E and
F. Width of the histogram corresponds to ΔτD = 3 ms. Y-axis range for each panel is from 0
to 60 %.
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Figure 5.
Distribution of diffusion times for α1-AT with WMDF (at 39 °C) as a function of the number
of days incubated. Width of the histogram corresponds to ΔτD = 3 ms. Y-axis range for each
panel is from 0 to 60 %.
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Figure 6.
Distribution of diffusion times for α1-AT with VIKF (at 39 °C) as a function of the number of
days incubated. The peptide concentration was kept at 200-fold molar excess over α1-AT.
Width of the histogram corresponds to ΔτD = 3 ms. Y-axis range for each panel is from 0 to
80 %.
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Figure 7.
Nondenaturing PAGE analysis of the reversal of TMR-P1′-AT polymerization with VIKF. (A)
TMR-labeled α1-AT polymers, (B) TMR-labeled α1-AT polymers + VIKF, incubated at 39 °
C for 21 days, (C) Unheated TMR-labeled α1-AT. The position of the monomer band is
shown.
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Figure 8.
Average diffusion times vs. the number of days incubated for the depolymerizing peptides
WMDF (black), VIKF (blue) and VEIF (red). In each case the diffusion times correspond to
an average of at least 50 individual measurements. For comparison, the average diffusion time
profile obtained for the control peptide FLKK (green) is also included.
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Figure 9.
Peptides bound in the β-sheet A pocket of the serpin, antithrombin.32 WMDF (yellow) bound
to antithrombin, as it appears in the crystal structure of the complex (pdb code: 1JVQ).35
Modeled structure of the designed peptide VIKF (magenta) containing the most probable
rotamer states.
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